BioSpace News Archive

- Evaluating 3 doses of olorinab in study participants with the clinical diagnosis of irritable bowel syndrome with predominant constipation (IBS-C) or diarrhea (IBS-D) - Topline data expected Q1 2021 - Significant unmet need for non-opioid, peripherally acting pain management in gastrointestinal disorders [01-October-2020] SAN DIEGO , Oct. 1, 2020

EyeGuide Inc., a health technology and bioinformatics company revolutionizing the way brain health is monitored, has announced the expansion of its scientific advisory board with the additions of Dr. Anne Naclerio, Dr. Dhiren Naidu, Dr. Jon Patricios, Dr. Kathryn Schneider, Dr. Karen Sutton and Dr. Michael Turner.

Amyris, Inc. announced that it is currently delivering samples to pharmaceutical companies of a sustainable and scalable alternative to shark-based vaccine adjuvants currently used in a number of vaccines, including those directed at influenza and COVID-19.

Imaging Healthcare Specialists has elevated patient experience, care and quality by engaging patients throughout the imaging encounter with Royal Enterprise Care™, a solution tailored to deliver the highest quality imaging workflows available in the industry.

DexCom, Inc. announced that it plans to release its third quarter 2020 financial results after market close on Tuesday, October 27, 2020.

Radius Health, Inc. announced that the company has successfully sold its second oncology pipeline asset – RAD 140 - to Ellipses Pharma Limited, completing Radius’s divestment of its oncology assets.

The potential contract value if the three-year extension option is exercised could be up to approximately £3.6 million (or approximately $4.6 million based on the current exchange rate)

VectorCare, a Sausalito-based SaaS company, recently unveiled a major rebranding, reflecting the company’s transformation to an all-in-one patient care logistics solution

Ontellus, the industry leading, nationwide full-service procurer of medical, billing, employment records, and other claims related data services, announces today that it has acquired INTERTEL, the largest medical records canvassing company, and MasterTrace.

Researchers at Intermountain Healthcare in Salt Lake City have developed a new clinical tool to accurately identify and diagnose COVID-19 patients who are at high risk of developing a serious inflammatory condition that can damage the lungs and other organs.